Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Bellet

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of the National Cancer Institute|May 1, 1991
Protection of central nervous system metastases from systemic chemotherapy by adrenal corticosteroidsR E Bellet
The Medical Clinics of North America|May 1, 1987
Preoperative evaluation of the oncology patientE F McClay, R E Bellet
The Journal of Urology|August 1, 1974
Estrogen-induced hypernephromaR E Bellet, A P Squitieri
Annals of Surgery|January 1, 1987
Frequency of occult residual melanoma after excision of a clinically positive regional lymph nodeM Kane, E McClay, R E Bellet
Annals of the New York Academy of Sciences|January 1, 1976
Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulantsM J Mastrangelo, D Berd, R E Bellet
JAMA|May 22, 1975
Cryptococcal pleural effusionJ D Smilack, R E Bellet, W T Talman
Lancet (London, England)|May 11, 1974
Letter: ICRF 159R E Bellet, M J Mastrangelo, L M Dixon
Journal of the National Cancer Institute|November 1, 1979
Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agentsR E Bellet, V Danna, M J Mastrangelo, et al.
Cancer|October 1, 1977
Multiple primary malignancies in patients with cutaneous melanomaR E Bellet, I Vaisman, M J Mastrangelo, et al.
Cancer Treatment Reports|December 1, 1978
Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosoureaR E Bellet, R B Catalano, M J Mastrangelo, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of the National Cancer Institute|May 1, 1991
Protection of central nervous system metastases from systemic chemotherapy by adrenal corticosteroidsR E Bellet
The Medical Clinics of North America|May 1, 1987
Preoperative evaluation of the oncology patientE F McClay, R E Bellet
The Journal of Urology|August 1, 1974
Estrogen-induced hypernephromaR E Bellet, A P Squitieri
Annals of Surgery|January 1, 1987
Frequency of occult residual melanoma after excision of a clinically positive regional lymph nodeM Kane, E McClay, R E Bellet
Annals of the New York Academy of Sciences|January 1, 1976
Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulantsM J Mastrangelo, D Berd, R E Bellet
JAMA|May 22, 1975
Cryptococcal pleural effusionJ D Smilack, R E Bellet, W T Talman
Lancet (London, England)|May 11, 1974
Letter: ICRF 159R E Bellet, M J Mastrangelo, L M Dixon
Journal of the National Cancer Institute|November 1, 1979
Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agentsR E Bellet, V Danna, M J Mastrangelo, et al.
Cancer|October 1, 1977
Multiple primary malignancies in patients with cutaneous melanomaR E Bellet, I Vaisman, M J Mastrangelo, et al.
Cancer Treatment Reports|December 1, 1978
Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosoureaR E Bellet, R B Catalano, M J Mastrangelo, et al.
Pageof 4